Search Results - "Stoeger, H" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

by Gnant, M., Filipits, M., Greil, R., Stoeger, H., Rudas, M., Bago-Horvath, Z., Mlineritsch, B., Kwasny, W., Knauer, M., Singer, C., Jakesz, R., Dubsky, P., Fitzal, F., Bartsch, R., Steger, G., Balic, M., Ressler, S., Cowens, J.W., Storhoff, J., Ferree, S., Schaper, C., Liu, S., Fesl, C., Nielsen, T.O.
Published in Annals of oncology (01.02.2014)

Get full text

Journal Article

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

by Gnant, M., Mlineritsch, B., Stoeger, H., Luschin-Ebengreuth, G., Knauer, M., Moik, M., Jakesz, R., Seifert, M., Taucher, S., Bjelic-Radisic, V., Balic, M., Eidtmann, H., Eiermann, W., Steger, G., Kwasny, W., Dubsky, P., Selim, U., Fitzal, F., Hochreiner, G., Wette, V., Sevelda, P., Ploner, F., Bartsch, R., Fesl, C., Greil, R.
Published in Annals of oncology (01.02.2015)

Get full text

Journal Article

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

by Gnant, M., Sestak, I., Filipits, M., Dowsett, M., Balic, M., Lopez-Knowles, E., Greil, R., Dubsky, P., Stoeger, H., Rudas, M., Jakesz, R., Ferree, S., Cowens, J.W., Nielsen, T., Schaper, C., Fesl, C., Cuzick, J.
Published in Annals of oncology (01.08.2015)

Get full text

Journal Article

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

by Steger, G.G., Greil, R., Lang, A., Rudas, M., Fitzal, F., Mlineritsch, B., Hartmann, B.L., Bartsch, R., Melbinger, E., Hubalek, M., Stoeger, H., Dubsky, P., Ressler, S., Petzer, A.L., Singer, C.F., Muss, C., Jakesz, R., Gampenrieder, S.P., Zielinski, C.C., Fesl, C., Gnant, M.
Published in Annals of oncology (01.02.2014)

Get full text

Journal Article

Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? Yes

Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? Yes

by Stöger, H
Published in Deutsche medizinische Wochenschrift (1946) (01.10.2013)

Get more information

Journal Article

62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer

62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer

by Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Poestlberger, S, Steger, G, Jakesz, R, Singer, C, Eidtmann, H, Greil, R
Published in Bone (New York, N.Y.) (01.01.2011)

Get full text

Journal Article

Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial

Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial

by Heidemann, E., Stoeger, H., Souchon, R., Hirschmann, W.-D., Bodenstein, H., Oberhoff, C., Fischer, J. T., Schulze, M., Clemens, M., Andreesen, R., Mahlke, M., König, M., Scharl, A., Fehnle, K., Kaufmann, M.
Published in Annals of oncology (01.11.2002)

Get full text

Journal Article

P286 Preplanned subgroup analysis of ABCSG-12 suggests that benefits of adjuvant zoledronic acid (ZOL) are most pronounced in lowest estrogen environment

P286 Preplanned subgroup analysis of ABCSG-12 suggests that benefits of adjuvant zoledronic acid (ZOL) are most pronounced in lowest estrogen environment

by Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Heck, D, Steger, G, Jakesz, R, Singer, C, Dubsky, P, Greil, R
Published in Breast (Edinburgh) (2011)

Get full text

Journal Article

8 Independent prognostic factors for response: updated results of the ABCSG-24 study evaluating the addition of capecitabine to epirubicin-docetaxel neoadjuvant therapy for early breast cancer (EBC)

8 Independent prognostic factors for response: updated results of the ABCSG-24 study evaluating the addition of capecitabine to epirubicin-docetaxel neoadjuvant therapy for early breast cancer (EBC)

by Steger, G.G, Greil, R, Jakesz, R, Lang, A, Mlineritsch, B, Rudas, M, Marth, C, Stoeger, H, Singer, C.F, Gnant, M
Published in European journal of cancer supplements (2010)

Get full text

Journal Article

68P Deciphering the interplay between nuclear RNA export factors and long non-coding RNAs in breast cancer metabolism

68P Deciphering the interplay between nuclear RNA export factors and long non-coding RNAs in breast cancer metabolism

by Klec, C., Schwarzenbacher, D., Gottschalk, B., Margit, R., Prinz, F., Bauernhofer, T., Stoeger, H., Graier, W.F., Pichler, M.
Published in Annals of oncology (01.05.2020)

Get full text

Journal Article

$P6237Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+ early breast cancer undergoing trastuzumab-based therapy$

P6237Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+ early breast cancer undergoing trastuzumab-based therapy

by Posch, F, Glantschnig, T, Firla, S, Smolle, M, Balic, M, Moik, F, Stoeger, H, Zirlik, A, Pichler, M, Rainer, P
Published in European heart journal (01.10.2019)

Get full text

Journal Article

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

by GNANT, M, PFEILER, G, GREIL, R, STEGER, G, SAMONIGG, H, FESL, C, JAKESZ, R, STÖGER, H, MLINERITSCH, B, FITZAL, F, BALIC, M, KWASNY, W, SEIFERT, M, STIERER, M, DUBSKY, P
Published in British journal of cancer (06.08.2013)

Get full text

Journal Article

Abstract P6-03-02: Independent evaluation of prognostic value of residual cancer burden (RCB) score on disease free and overall survival of breast cancer patients treated with neoadjuvant systemic treatment at a single institution

Abstract P6-03-02: Independent evaluation of prognostic value of residual cancer burden (RCB) score on disease free and overall survival of breast cancer patients treated with neoadjuvant systemic treatment at a single institution

by Balic, M, Mueller, DH, Hammer, R, Gumpoldsberger, M, Suppan, C, Posch, F, Stoeger, H, Dandachi, N, Prein, K, Hauser, H, Lax, S
Published in Cancer research (Chicago, Ill.) (15.02.2018)

Get full text

Journal Article

Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance

Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance

by Riedl, J., Posch, F., Stotz, M., Bezan, A., Winder, T., Schaberl-Moser, R., Pichler, M., Stoeger, H., Gerger, A.
Published in Annals of oncology (01.10.2016)

Get full text

Journal Article

An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer

An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer

by Winder, T., Posch, F., Asamer, E., Stotz, M., Siebenhüner, A., Schlick, K., Magnes, T., Samaras, P., Szkandera, J., Clavien, P.-A., Neureiter, D., Greil, R., Pestalozzi, B.C., Stoeger, H., Gerger, A., Egle, A., Pichler, M.
Published in Annals of oncology (01.10.2016)

Get full text

Journal Article

Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival

Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival

by GARY, T, BELAJ, K, BRODMANN, M, STEIDL, K, PICHLER, M, EISNER, F, STÖGER, H, HAFNER, F, FROEHLICH, H, SAMONIGG, H, PILGER, E
Published in British journal of cancer (09.10.2012)

Get full text

Journal Article

Long-term cardiovascular complications in stage I seminoma patients

Long-term cardiovascular complications in stage I seminoma patients

by Terbuch, A., Posch, F., Annerer, L. M., Bauernhofer, T., Pichler, M., Szkandera, J., Hutterer, G. C., Pummer, K., Partl, R., Kapp, K. S., Stöger, H., Gerger, A., Stotz, M.
Published in Clinical & translational oncology (01.11.2017)

Get full text

Journal Article

Abstract P6-10-01: Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)

Abstract P6-10-01: Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)

by Singer, CF, Pfeiler, G, Hubalek, M, Bartsch, R, Stoeger, H, Pichler, A, Petru, E, Greil, R, Rudas, M, Tea, M-KM, Wette, V, Petzer, AL, Sevelda, P, Egle, D, Dubsky, PC, Balic, M, Tinchon, C, Bago-Horvath, Z, Frantal, S, Michael, G
Published in Cancer research (Chicago, Ill.) (15.02.2017)

Get full text

Journal Article

Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy

Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy

by Mollnar, S., Pondorfer, P., Kasparek, A.-K., Reinisch, S., Moik, F., Stotz, M., Halm, M., Szkandera, J., Terbuch, A., Eisner, F., Gerger, A., Kapp, K. S., Partl, R., Vasicek, S., Weiland, T., Pichler, M., Stöger, H., Thurnher, D., Posch, F.
Published in Clinical & translational oncology (01.03.2021)

Get full text

Journal Article

Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study

Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study

by Barth, D. A., Riedl, J. M., Posch, F., Smolle, M. A., Kasparek, A.-K., Niedrist, T., Szkandera, J., Stöger, H., Pichler, M., Stotz, M., Gerger, A.
Published in Clinical & translational oncology (01.08.2019)

Get full text

Journal Article